Pulmonary AVM Embolization
- A pulmonary arteriovenous malformation (PAVM) is a short-circuit: a pulmonary artery dumps straight into a pulmonary vein, skipping the capillary bed that normally filters and oxygenates blood.
- That unfiltered shunt is dangerous less for what it does to oxygen and more for what it lets through — clots and bacteria sail past the lungs and into the brain, causing strokes and brain abscesses.
- Most PAVMs are tied to hereditary hemorrhagic telangiectasia (HHT); finding one should make you hunt for more and ask about the family.
- The fix is embolization: thread a catheter to the feeding artery and plug it with coils or a vascular plug, killing the shunt while sparing normal lung.
- The number that matters is the diameter of the feeding artery, not the size of the tangled sac — that's what determines whether you treat and what you plug it with.
Imagine the lung as airport security. Every drop of blood is supposed to file through the capillaries — the body's metal detector — where it picks up oxygen and gets screened for contraband like clots and bacteria. A pulmonary AVM is the unguarded side door. Blood strolls straight from the artery to the vein, no screening, no oxygen pickup, waving at the security line on its way past.
The cruel twist is that this is mostly a brain problem wearing a lung costume. We embolize PAVMs less to fix breathlessness and more to slam that side door shut before a clot uses it to reach the head.
Why a short-circuit in the lung threatens the brain
Normal capillaries are a fine mesh. A tiny clot from a leg vein, or a clump of bacteria from a dental cleaning, gets caught there and dealt with. With a PAVM, the mesh is bypassed. Anything in the venous blood gets a free, express ride through the heart and straight up the carotids.
That's why the headline complications are paradoxical embolism — a clot crossing right-to-left to cause an ischemic stroke — and brain abscess, where bacteria that should have been filtered set up camp in the brain instead. Patients can also be hypoxic or cough up blood if a PAVM bleeds (and the nosebleeds of the underlying HHT are often what brought them in), but it's the neurologic risk that earns the procedure.
This is a right-to-left shunt: deoxygenated blood skips the lungs. That's the opposite of the more famous left-to-right cardiac shunts. The practical consequence — debris reaching the systemic circulation — is what makes even small, symptom-free PAVMs worth treating.
Who has them, and why you should snoop
Most PAVMs aren't random plumbing flukes. They're strongly associated with hereditary hemorrhagic telangiectasia (HHT), a genetic condition that sprinkles fragile abnormal vessels throughout the body. So a PAVM is rarely a solo act.
Find one PAVM and you should assume there are more — they're frequently multiple — and ask about nosebleeds and family history. One quiet PAVM on a CT can be the loose thread that unravels an undiagnosed HHT family.
The one measurement that runs the show
When deciding whether to treat, the radiologist isn't mesmerized by the big tangled sac. The number that matters is the diameter of the feeding artery — the inflow pipe.
The logic is the plumber's, not the poet's: the feeding artery is what you actually plug, and its size sets the risk that debris can pass through. Historically a feeding artery around 3 mm or larger was the treat-it threshold, though many operators now treat smaller feeders when they can be reached safely. The point is that the feeder, not the showy malformation, drives the decision.
How the embolization actually goes
The procedure is a tidier cousin of angiography and embolization elsewhere in the body. From a vein — usually the femoral or jugular — a catheter is steered through the right heart into the pulmonary arteries and out to the feeding artery of the PAVM. A pulmonary angiogram maps the anatomy: one feeder or several, where the draining vein sits, and exactly where to deploy.
Then the operator parks an occlusion device in that feeding artery. The two workhorses are coils (little springy wires that pack in and clot off) and vascular plugs (a mesh basket that seals a vessel in one shot). The goal is to plant the device as close to the AVM sac as is safe while sparing the normal lung branches upstream.
Two classic disasters: deploying too proximally leaves side branches that re-feed the malformation, so the shunt comes back to life later. And the device itself can slip through the low-resistance shunt and embolize into the systemic circulation — the very paradoxical-embolism event the whole procedure exists to prevent. Careful sizing and positioning are everything.
Afterward, and the long game
Success looks delightfully boring: the angiogram shows the sac no longer filling, and over time it shrinks and may scar down. Patients can get a transient bout of pleuritic chest pain as the embolized segment infarcts a little — usually self-limited.
The catch is that PAVMs are recurrence-prone. Feeders can recanalize, and in HHT, brand-new ones can grow over the years. So these patients live on a surveillance schedule, typically with periodic CT follow-up rather than a one-and-done.
The mission isn't to make the CT look pretty — it's to reclose the unguarded side door so that the next stray clot or cluster of bacteria gets stopped at the capillary checkpoint instead of reaching the brain.
If you've read about how clots reach the lungs in pulmonary embolism, a PAVM is the unsettling sequel: here the clot doesn't stop in the lung — it uses the lung as a shortcut to somewhere far worse.